双重二酰甘油激酶（DGK）α/ζ 抑制剂在体内和离体模型中增强人 TIL（肿瘤浸润淋巴细胞）的活性

A dual diacylglycerol kinase (DGK) alpha/zeta inhibitor augments the activity of human tumor infiltrating lymphocytes in in vivo and ex vivo models.

分泌 T 细胞衔接器的 CD4(+) TIL（肿瘤浸润淋巴细胞）诱导自体患者来源非小细胞肺癌异种移植瘤消退

CD4(+) tumor-infiltrating lymphocytes secreting T cell-engagers induce regression of autologous patient-derived non-small cell lung cancer xenografts.

高级别胶质瘤的免疫治疗与靶向治疗：当前与未来方向

Immunotherapy and targeted therapy for high grade gliomas: current and future directions.

高级别胶质瘤是一种网络性疾病，涉及众多相互关联的分子和微环境现象，从肿瘤内在通路和抗原性到免疫识别与攻击，再到神经元对肿瘤和免疫信号的调控。新兴疗法通常同时利用其中若干交叉机制，为这些毁灭性癌症的未来临床治疗带来了希望。不适用。

拓展 CAR-T 细胞与双特异性 T 细胞衔接器在实体瘤中的治疗覆盖范围

Expanding the Therapeutic Reach of Chimeric Antigen Receptor T-Cells and Bispecific T-Cell Engagers Across Solid Tumors.

非小细胞肺癌中 TIL（肿瘤浸润淋巴细胞）的扩增：EGFR 突变亚群中的临床潜力和疗效

Expansion of tumor-infiltrating lymphocytes in non-small cell lung cancer: Clinical potential and efficacy in EGFR mutation subsets.